Literature DB >> 11420685

Tumor suppressor protein VHL is induced at high cell density and mediates contact inhibition of cell growth.

M Baba1, S Hirai , S Kawakami, T Kishida, N Sakai, S Kaneko, M Yao, T Shuin, Y Kubota, M Hosaka, S Ohno.   

Abstract

In spite of the general recognition of von Hippel-Lindau (VHL) as a tumor suppressor gene, the physiological and pathological importance of VHL protein in cell growth regulation and tumorigenesis remains unclear. Here we show that in normal human renal proximal tubule epithelial cells (RPTEC), the steady-state amount of VHL protein is strictly regulated by cell density. The cellular VHL content is more than 100-fold higher in dense cultures than in sparse cultures. The increase in VHL protein at high cell density was also observed for NIH3T3 fibroblasts, suggesting the generality of the phenomenon. The growth rates of renal cell carcinoma cells lacking an intact VHL gene and their derivatives with wild-type or mutant VHL expression vector do not differ significantly when they are growing in log-phase. Importantly, however, there is a difference when they reach confluency: cells lacking wild-type VHL grew continuously, while cells expressing exogenous VHL protein showed relatively limited cell growth. Using an ecdysone-inducible VHL expressing cell line, we also show that the growth inhibition at high cell density can be released by attenuating the VHL expression. Taken together, we propose that VHL protein functions as a growth suppressor at high cell density, and this might be the basis of the tumor suppressor function of VHL.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420685     DOI: 10.1038/sj.onc.1204397

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

1.  Molecular characterization of mouse gastric epithelial progenitor cells.

Authors:  Jason C Mills; Niklas Andersson; Chieu V Hong; Thaddeus S Stappenbeck; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-30       Impact factor: 11.205

2.  Obligate roles for p16(Ink4a) and p19(Arf)-p53 in the suppression of murine pancreatic neoplasia.

Authors:  Nabeel Bardeesy; Jeffrey Morgan; Manisha Sinha; Sabina Signoretti; Shefali Srivastava; Massimo Loda; Glenn Merlino; Ronald A DePinho
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

3.  Jade-1, a candidate renal tumor suppressor that promotes apoptosis.

Authors:  Mina I Zhou; Rebecca L Foy; Vipul C Chitalia; Jin Zhao; Maria V Panchenko; Hongmei Wang; Herbert T Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-26       Impact factor: 11.205

4.  VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail.

Authors:  Andrew J Evans; Ryan C Russell; Olga Roche; T Nadine Burry; Jason E Fish; Vinca W K Chow; William Y Kim; Arthy Saravanan; Mindy A Maynard; Michelle L Gervais; Roxana I Sufan; Andrew M Roberts; Leigh A Wilson; Mark Betten; Cindy Vandewalle; Geert Berx; Philip A Marsden; Meredith S Irwin; Bin T Teh; Michael A S Jewett; Michael Ohh
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

5.  Cellular quiescence induced by contact inhibition or serum withdrawal in C3H10T1/2 cells.

Authors:  M Gos; J Miloszewska; P Swoboda; H Trembacz; J Skierski; P Janik
Journal:  Cell Prolif       Date:  2005-04       Impact factor: 6.831

Review 6.  Practical uses for ecdysteroids in mammals including humans: an update.

Authors:  R Lafont; L Dinan
Journal:  J Insect Sci       Date:  2003       Impact factor: 1.857

Review 7.  Choosing the right cell line for renal cell cancer research.

Authors:  Klaudia K Brodaczewska; Cezary Szczylik; Michal Fiedorowicz; Camillo Porta; Anna M Czarnecka
Journal:  Mol Cancer       Date:  2016-12-19       Impact factor: 27.401

8.  Cell type- and density-dependent effect of 1 T static magnetic field on cell proliferation.

Authors:  Lei Zhang; Xinmiao Ji; Xingxing Yang; Xin Zhang
Journal:  Oncotarget       Date:  2017-02-21

9.  Hypermethylation and loss of retinoic acid receptor responder 1 expression in human choriocarcinoma.

Authors:  H Huebner; R Strick; D L Wachter; S Kehl; P L Strissel; R Schneider-Stock; A Hartner; W Rascher; L C Horn; M W Beckmann; M Ruebner; F B Fahlbusch
Journal:  J Exp Clin Cancer Res       Date:  2017-11-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.